Over the last 180 days, Pyxis Oncology, Inc. insiders sold a net $107.1K of stock across 25 Form 4 purchases and sales, with 0 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-06.
Showing the most recent few. Create a free account to see 20 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| REVENUE | $13.9M | $16.1M | — | — |
| OPERATING INCOME | $-84.4M | $-89.5M | $-82.2M | $-123.5M |
| NET INCOME | $-79.6M | $-77.3M | $-73.8M | $-120.7M |
| EPS (DILUTED) | -1.28 | -1.32 | -1.85 | -3.65 |
| OPERATING CASH FLOW | $-63.5M | $-57.7M | $-70.7M | $-89.3M |
| CASH | $15.4M | $19.5M | $9.7M | $179.3M |
No password to create and no card required. We store your email address and nothing else.